| Symbol | PROF |
|---|---|
| Name | PROFOUND MEDICAL CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 2400 SKYMARK AVENUE,UNIT 6, MISSISSAUGA, Ontario, L4W 5K5, Canada |
| Telephone | +1 647 - 476-1350 |
| Fax | — |
| — | |
| Website | https://www.profoundmedical.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001628808 |
| Description | Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare systems existing imaging infrastructure. The companys product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customers existing MRI scanner. Additional info from NASDAQ: |
(70% Positive) PROFOUND MEDICAL CORP. (PROF) Announces Clinical Development Update
Read moreProfound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full‘TULSA Days’
Read more(83% Neutral) PROFOUND MEDICAL CORP. (PROF) Provides Update on innovator for interventional MRI (iMRI) procedures
Read moreProfound Medical Launches ‘Lets Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
Read more(99% Neutral) PROFOUND MEDICAL CORP. (PROF) Reports Q3 2026 Financial Results
Read moreProfound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
Read moreProfound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
Read more